Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Model Agreement Group Initiative (MAGI) is a leading clinical research organization and consortium dedicated to improving the efficiency and quality of clinical trials through standardization and best practices. Founded in 2003 and acquired by WCG in 2019, MAGI provides a platform for clinical research professionals to share expertise, standardize processes, and streamline contract negotiations. The organization is widely recognized for its semi-annual conferences and its 'Model Clinical Trial Agreement' (CTA) template, which is utilized by hundreds of sponsors, CROs, and research sites globally. MAGI's mission is to reduce the administrative burden of clinical research, thereby accelerating the delivery of new medical treatments to patients. Through its training programs and the Journal of Clinical Research Best Practices, MAGI supports the professional development and compliance of the clinical research workforce.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Model Agreement Group Initiative.